Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 10, 1999

View Archived Issues

Vivus ends license agreement for gene therapy treatment for erectile dysfunction

Company Profile: Biopure

Acetylcholine releaser SM-21 improves cognitive functions in rats and mice

Intravenous zanamivir offers potential against influenza A

New naturally occurring hepatoprotective/immunostimulating compound from Il Yang in phase II

Roche to submit sNDA for Xeloda as first-line colorectal cancer therapy

Vitrix soon to enter expanded clinical development

Allosteric adenosine receptor modulators described by Medco

Potent and selective, optically active alpha1-adrenoceptor ligands developed in Taiwan

Recently issued U.S. patent covers Searle's newest p38 MAP kinase inhibitors

Agents for allergic diseases in development by Dainippon Ink & Chemicals

Phthalazinones synthesized at Byk Gulden specifically inhibit PDE4

New triazoles from SSP display excellent antifungal activity in preliminary tests

Important market launch for Ziagen

IPA: a potent endogenous antioxidant and neuroprotective agent

Health Canada approves new type II diabetes treatment from Novo Nordisk

Arava approved in Europe for rheumatoid arthritis

U.S. and Canadian academics design novel prodrug approach to 5-FU chemotherapy

Fujisawa seeks approval for tacrolimus ointment in the U.S.

AstraZeneca launches new Zomig formulation for migraine

Huperzine A improves cognition in Chinese adolescent students

NovoRapid approved in E.U. for treatment of diabetes

Wider therapeutic index predicted for Ditropan XL compared to conventional Ditropan

Health Canada grants priority review status for new flu pill

Potential new treatment for Friedreich's ataxia: idebenone

Access initiates clinical trial of OraDisc for amlexanox delivery

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...